The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples.
DHRS7
EGFR
STAT3
androgen
metabolism
phosphorylation
prostate cancer
survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Jun 2022
23 Jun 2022
Historique:
received:
01
06
2022
revised:
20
06
2022
accepted:
21
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Prostate cancer (PCa), one of the most common malignancies in men, typically responds to initial treatment, but resistance to therapy often leads to metastases and death. The dehydrogenase/reductase 7 (DHRS7, SDR34C1) is an "orphan" enzyme without known physiological function. DHRS7 was previously found to be decreased in higher-stage PCa, and siRNA-mediated knockdown increased the aggressiveness of LNCaP cells. To further explore the role of DHRS7 in PCa, we analyzed the proteome of LNCaP cells following
Identifiants
pubmed: 35804847
pii: cancers14133074
doi: 10.3390/cancers14133074
pmc: PMC9264982
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Swiss National Science Foundation
ID : 31003A-179400
Pays : Switzerland
Références
Science. 1994 Apr 1;264(5155):95-8
pubmed: 8140422
Cancer Med. 2015 Nov;4(11):1717-29
pubmed: 26311046
Cancers (Basel). 2021 Dec 30;14(1):
pubmed: 35008337
Clin Prostate Cancer. 2003 Jun;2(1):50-7
pubmed: 15046685
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3207-12
pubmed: 10716737
Oncogene. 2001 May 3;20(20):2499-513
pubmed: 11420660
Cancer Res. 2002 Nov 15;62(22):6659-66
pubmed: 12438264
Chem Biol Interact. 2014 Jan 25;207:52-7
pubmed: 24246760
Cancer Res. 2006 Mar 1;66(5):2815-25
pubmed: 16510604
Nucleic Acids Res. 2009 Jul;37(12):4135-48
pubmed: 19433513
J Steroid Biochem Mol Biol. 2015 Jan;145:144-56
pubmed: 24925260
Nat Rev Urol. 2018 Apr;15(4):222-234
pubmed: 29460925
J Biol Chem. 1997 Jun 20;272(25):15959-66
pubmed: 9188497
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6579-84
pubmed: 18006757
Science. 1987 Jul 17;237(4812):268-75
pubmed: 3037703
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
pubmed: 11252954
Theranostics. 2021 Feb 15;11(9):4011-4029
pubmed: 33754045
J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):112-9
pubmed: 26466768
N Engl J Med. 2008 Mar 13;358(11):1160-74
pubmed: 18337605
Nat Rev Dis Primers. 2021 Feb 4;7(1):9
pubmed: 33542230
J Steroid Biochem Mol Biol. 2017 Jul;171:288-295
pubmed: 28457967
Nat Rev Urol. 2018 Mar;15(3):191-196
pubmed: 29231195
Mol Cell Endocrinol. 2007 Feb;265-266:77-82
pubmed: 17223255
Int J Biol Macromol. 2017 Dec;105(Pt 1):171-182
pubmed: 28687384
J Clin Endocrinol Metab. 1996 Jan;81(1):130-6
pubmed: 8550739
Br J Cancer. 2004 Jan 26;90(2):449-54
pubmed: 14735192
Am J Pathol. 2001 Jan;158(1):25-32
pubmed: 11141475
Neuropsychopharmacology. 2016 Jan;41(1):261-74
pubmed: 26250598
BJU Int. 2007 Oct;100(4):765-9
pubmed: 17822457
J Clin Invest. 2012 May;122(5):1920-32
pubmed: 22505453
Nat Rev Cancer. 2012 Jul 12;12(8):553-63
pubmed: 22785351
Nat Med. 2002 Mar;8(3):289-93
pubmed: 11875501
Methods Enzymol. 2000;316:372-83
pubmed: 10800688
Urol Oncol. 2013 Jan;31(1):82-6
pubmed: 21396844
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Urol Oncol. 2014 Jul;32(5):707-13
pubmed: 24629494
Nat Med. 2016 Mar;22(3):298-305
pubmed: 26855148
Oncol Rep. 2009 Mar;21(3):731-5
pubmed: 19212633
Pharmacol Rev. 2002 Jun;54(2):161-202
pubmed: 12037135
J Biol Chem. 2003 Oct 31;278(44):43060-6
pubmed: 12939263
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Nat Rev Cancer. 2004 Feb;4(2):97-105
pubmed: 14964307
Cell Rep. 2018 Dec 18;25(12):3530-3542.e5
pubmed: 30566875
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Nat Genet. 1994 May;7(1):34-9
pubmed: 8075637
Cancer Res Treat. 2012 Mar;44(1):50-6
pubmed: 22500161
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Br J Clin Pharmacol. 2017 Mar;83(3):653-663
pubmed: 27735065
Cell Mol Life Sci. 2016 Dec;73(23):4397-4413
pubmed: 27342992
Mol Syst Biol. 2005;1:2005.0010
pubmed: 16729045
Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1790-800
pubmed: 17311890
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Oncogene. 2003 Jul 3;22(27):4150-65
pubmed: 12833138
Br J Clin Pharmacol. 2021 Apr;87(4):1801-1813
pubmed: 32986870
Br J Cancer. 2007 Oct 22;97(8):1139-45
pubmed: 17940504
Urology. 2009 Sep;74(3):665-71
pubmed: 19616281
Mol Endocrinol. 2006 Feb;20(2):444-58
pubmed: 16179381
Clin Cancer Res. 2012 Nov 1;18(21):6049-57
pubmed: 22977195
Front Mol Neurosci. 2019 Sep 20;12:224
pubmed: 31616248
J Cell Physiol. 2019 May;234(5):7548-7559
pubmed: 30367494
J Biol Chem. 2001 Oct 19;276(42):38830-6
pubmed: 11495901
Ann Oncol. 2008 Sep;19(9):1624-8
pubmed: 18467313
Nat Rev Cancer. 2001 Oct;1(1):34-45
pubmed: 11900250
Cell. 2018 Jul 12;174(2):433-447.e19
pubmed: 29909985